Position in LQDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,050,443
+$1,939,343 QoQ
Shares Held
50,802
-9.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#90
of 333 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
498,222 | $26,106,832 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
64,908 | $10,939,594 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
71,901 | $4,598,068 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
240,060 | $4,155,438 | |
| 5 | LQDA |
Liquidia Corp
This page
|
50,802 | $4,050,443 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
32,860 | $2,720,150 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
408,064 | $1,717,949 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,931 | $1,206,050 |
All Filings in LQDA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,050,443 | 50,802 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,111,100 | 55,938 | Shares | Sole | 2026-05-22 | |
| No filing history on record for this holder in this stock. | ||||||